J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
Munich University Hospital
UCSF Medical Center
New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression
New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!
Keio University Hospital
